“Trade of the Day” for Monday, March 17

This is a very aggressive stock that fell significantly throughout last week after tripling during the past 2-3 months. While the risk here is obvious given the price of the stock and the fact that it’s in the biotech industry, entry at the current price is certainly much better from a reward to risk perspective than a week ago…